Your Location:
Home >
Browse articles >
Effect of Xiangsha Liu Junzitang on dyHDL in Hyperlipidemia Rats with Spleen Deficiency
Effect of Xiangsha Liu Junzitang on dyHDL in Hyperlipidemia Rats with Spleen Deficiency
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 7, Pages: 22-28(2019)
DOI: 10.13422/j.cnki.syfjx.20190737
Scan QR Code
Full Text(HTML)
Figs( 1 ) Tabs( 3 )
References
Publication Info
Metrics
55
Views
78
Downloads
10
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanisms and Clinical Research Advances of Curcumin in Modulation of Hyperlipidemia
Hyperlipidemia Animal Models Based on Disease-syndrome Clinical Characteristics of Traditional Chinese and Western Medicine
Traditional Chinese Medicine Intervening Signaling Pathways Related to Type 2 Diabetes Mellitus Complicated with Hyperlipidemia: A Review
Danlianxin Formula Ameliorates Cardiac Dysfunction Associated with Myocardial Infarction in Hyperlipidemic Rats via Epac1/VDAC1/NLRP3/Caspase Signaling Pathway
Differences in Expression of Intestinal Flora in Patients with Different TCM Syndrome Types of "Yang Huang-Yin-Yang Huang-Yin Huang" in Hepatitis B Virus-related Acute-on-chronic Liver Failure
Related Author
ZENG Zhijun
LU Wenjie
MA Xiaoxue
JI Yanhua
TONG Yun
LING Siyu
ZENG Yue
LE Chao
Related Institution
Research Center for Differentiation and Development of Basic Theories of Traditional Chinese Medicine(TCM), Jiangxi University of TCM
Jiangxi Key Laboratory of TCM Etiology Biology
Shandong Medicine Technician College
School of Sports Health, Jiangxi University of TCM
AIDS Clinical Research Center, The First Affiliated Hospital of Henan University of Chinese Medicine


